Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events.
about
Soluble Urokinase-type Plasminogen Activator Receptor Predicts All-cause 5-Year Mortality in Ischemic Stroke and TIA.Serum Soluble Urokinase-Type Plasminogen Activator Receptor Is Associated with Low Left Ventricular Ejection Fraction and Elevated Plasma Brain-Type Natriuretic Peptide LevelCoronary Artery Disease Severity and Cardiovascular Biomarkers in Patients with Peripheral Artery DiseaseSoluble Urokinase Receptor and Chronic Kidney Disease.Soluble urokinase plasminogen activation receptor--An emerging new biomarker of cardiovascular disease and critical illness.Introduction of a prognostic biomarker to strengthen risk stratification of acutely admitted patients: rationale and design of the TRIAGE III cluster randomized interventional trial.Pathway-Specific Aggregate Biomarker Risk Score Is Associated With Burden of Coronary Artery Disease and Predicts Near-Term Risk of Myocardial Infarction and Death.Novel biomarkers of coronary microvascular disease.Circulating soluble urokinase plasminogen activator receptor levels and peripheral arterial disease outcomes.A tripartite complex of suPAR, APOL1 risk variants and αvβ3 integrin on podocytes mediates chronic kidney disease.Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.Soluble urokinase plasminogen activator receptor and hypertension among black South Africans after 5 years.Depression and chest pain in patients with coronary artery disease.Association between serum soluble urokinase-type plasminogen activator receptor and atrial fibrillationSoluble urokinase-type plasminogen activator receptor: a useful biomarker for coronary artery disease and clinical outcomes?Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study.Soluble Urokinase Plasminogen Activator Receptor and the Risk of Coronary Artery Disease in Young Chinese Patients.Clinical and prognostic usefulness of soluble urokinase plasminogen activator receptor in hemodialysis patients.suPAR is associated with risk of future acute surgery and post-operative mortality in acutely admitted medical patients.SuPAR predicts postoperative complications and mortality in patients with asymptomatic aortic stenosis.The intriguing role of soluble urokinase receptor in inflammatory diseases.Association between suPAR and cardiac diastolic dysfunction among patients with preserved ejection fraction.Plasma suPAR is lowered by smoking cessation: a randomized controlled study.Predicting Mortality in African Americans With Type 2 Diabetes Mellitus: Soluble Urokinase Plasminogen Activator Receptor, Coronary Artery Calcium, and High-Sensitivity C-Reactive Protein.Local Production of Soluble Urokinase Plasminogen Activator Receptor and Plasminogen Activator Inhibitor-1 in the Coronary Circulation Is Associated With Coronary Endothelial Dysfunction in Humans
P2860
Q33770773-0EE7FEC7-5EB5-4E98-A987-E80254086001Q36263895-69DEB2BB-8311-4254-B376-58D96B6AE643Q36307793-05ECAF26-4937-4D1B-9C1D-95FADDBEF283Q36429637-8B5ECE0B-D945-4FB4-90E8-2488818278A3Q36987888-57E3DE37-8730-4A71-8952-4BE06F57AD16Q37154114-CBF4E2AC-8AF5-483E-932B-F6748083DE83Q38747883-B52AA19C-1F81-4080-97E6-5ED13A56DB35Q38854433-DBF09F2B-AA24-4B82-AF88-0DAA872490ACQ40114454-3CDC851D-4033-43E5-AE96-16BC85AA2A7EQ40145523-51A1EB01-AA4E-4149-806D-B66A13D162C7Q40216229-280824AE-C47E-4781-A2FC-85D40830E8E8Q40261498-D3871D49-01A0-457D-8BB8-2BA175A159A7Q40400175-466539AC-E073-4F34-AE24-6DC7B6B5E734Q42265982-DE7A6E21-24C5-4212-BB43-2254D582A4A0Q43142106-6F59EDBE-BC40-4B76-8717-FFF77BC6F503Q44256854-0BFB96C3-4D66-4432-920E-2A4E975DFC9AQ45306072-CEEC938C-C6B1-4EC3-B113-5F05B8E38CC2Q47219920-649A5CDF-37AF-4732-80A4-5C0A581D8E4BQ47698573-BC12E9AD-6409-4079-9A67-1F26EB717D27Q47700751-B20696EE-B280-49B3-A38A-C18AB2CBA4D9Q49124480-86CEF5E7-0F7B-4666-8D93-BC23D9AE800CQ50955643-03CAADB6-A43A-4643-9E07-D5EEE80897E1Q53202443-2FE05339-D817-4268-9DF7-4C13358BCCEFQ53687325-B34BE65C-4142-40F1-8ED1-BB0D96F85023Q58130073-9CFB135D-855D-43D4-838C-B6F63954E5D9
P2860
Soluble urokinase plasminogen activator receptor level is an independent predictor of the presence and severity of coronary artery disease and of future adverse events.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Soluble urokinase plasminogen ...... and of future adverse events.
@ast
Soluble urokinase plasminogen ...... and of future adverse events.
@en
type
label
Soluble urokinase plasminogen ...... and of future adverse events.
@ast
Soluble urokinase plasminogen ...... and of future adverse events.
@en
prefLabel
Soluble urokinase plasminogen ...... and of future adverse events.
@ast
Soluble urokinase plasminogen ...... and of future adverse events.
@en
P2093
P2860
P356
P1476
Soluble urokinase plasminogen ...... and of future adverse events.
@en
P2093
Aristea Velegraki
Arshed A Quyyumi
Christian W Thorball
Danny J Eapen
Dimitrios T Kremastinos
Emir Veledar
Hatem Al Kassem
Laurence Sperling
Muhammad Hammadah
Ngoc-Anh Le
P2860
P304
P356
10.1161/JAHA.114.001118
P577
2014-10-23T00:00:00Z